2021 annual financial data
Beam Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -127.82%.
Operating income was -392,465,000 USD and net income was -370,638,000 USD.
Operating cash flow was -66,268,000 USD.
Get free Beam Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 51,844,000 USD
- Operating income
- -392,465,000 USD
- Net income
- -370,638,000 USD
- Operating cash flow
- -66,268,000 USD